To take your ideas to Policymakers, Join the Campaign of #PolicyPulse Write to feedback@policypulse.com

After cough syrups, more drugs may face ban

At least 500 more medicines, might soon face a ban for being unsafe and inefficacious, a report that appeared in ‘The Times of India’ online has said.

Policy Pulse
Publish Date: Mar 15 2016 12:38PM | Updated Date: Mar 16 2016 10:46AM

After cough syrups, more drugs may face ban

 At least 500 more medicines, might soon face a ban for being unsafe and inefficacious, a report that appeared in ‘The Times of India’ online has said.

 
According to it, the Health Ministry, which has banned 344 fixed-dose combinations (FDCs) including cough syrups like Benedryl and Corex few days back, is assessing a list of over 6,000 products. 
 
At least 1,000 such FDCs are under scrutiny right now and as many as 500 of them are likely to face a ban in few months, the report quoted an official as saying.
 
Ministry is of the view that unreasonable FDCs are causing anti-microbial resistance and toxicity are so high insome cases that it may even result in failure of organs. 
 
Delhi High Court on Monday had granted Pfizer a stay order on ban on its popular cough syrup Corex.
 
A few of drug making companies have argued that some banned drugs have been available in India for around 30 years to make a point for safety and effectiveness , health ministry officials contend that a long market life is not sufficient to prove safety .